Brainstorm Cell Therapeutics Inc. (BCLI)

NASDAQ: BCLI · IEX Real-Time Price · USD

0.532

-0.013 (-2.39%)

At close: Apr 25, 2024, 4:00 PM

0.510

-0.022 (-4.12%)

After-hours: Apr 25, 2024, 7:53 PM EDT

BCLI Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Net Income	-17.19	-24.28	-24.46	-31.81	-23.25	-13.95	-4.95	-4.98	-8.49	-9.25	Upgrade
Depreciation & Amortization	0.27	0.29	0.26	0.22	0.16	0.11	0.09	0.08	0.09	0.11	Upgrade
Share-Based Compensation	1.49	1.68	1.37	2.56	0.76	0.92	0.55	0.64	0.84	1.02	Upgrade
Other Operating Activities	-5.02	2.99	-3.43	-6.16	11.08	0.53	1.95	-1.59	0.16	3.63	Upgrade
Operating Cash Flow	-20.46	-19.32	-26.27	-35.19	-11.25	-12.39	-2.36	-5.86	-7.41	-4.49	Upgrade
Capital Expenditures	-0.02	-0.03	-0.33	-0.38	-0.47	-0.37	-0.18	-0.1	-0.05	-0.16	Upgrade
Change in Investments	2.21	1.03	0.65	-4.07	6.09	-0.85	4.17	6.08	-11.24	-4.29	Upgrade
Investing Cash Flow	2.19	1	0.32	-4.45	5.62	-1.22	3.99	5.98	-11.28	-4.45	Upgrade
Share Issuance / Repurchase	18.98	0.24	6.97	76.94	5.23	0.03	0.31	0	14.87	10.29	Upgrade
Other Financing Activities	-	-	-	-	-	12.04	-	-	-	-0.6	Upgrade
Financing Cash Flow	18.98	0.24	6.97	76.94	5.23	12.07	0.31	0	14.87	9.69	Upgrade
Net Cash Flow	0.71	-18.08	-18.97	37.29	-0.41	-1.54	1.94	0.12	-3.82	0.75	Upgrade
Free Cash Flow	-20.48	-19.35	-26.6	-35.57	-11.72	-12.76	-2.54	-5.96	-7.45	-4.65	Upgrade
Free Cash Flow Per Share	-0.47	-0.53	-0.73	-1.19	-0.54	-0.64	-0.14	-0.32	-0.41	-0.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).